We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Regulatory requirements in the development of advanced therapy products (cell-, gene therapy, tissue engineering products)
Poster

Regulatory requirements in the development of advanced therapy products (cell-, gene therapy, tissue engineering products)

Regulatory requirements in the development of advanced therapy products (cell-, gene therapy, tissue engineering products)
Poster

Regulatory requirements in the development of advanced therapy products (cell-, gene therapy, tissue engineering products)

Regulatory authorities are active to ensure a good regulatory environment for somatic cell therapy-, gene therapy- and tissue engineering products (in the EU known as ‘Advanced Therapy Medicinal Products’). Both the EMEA and the FDA have, amongst others, issued guidelines to address the specific aspects of these products
Advertisement